Biến chứng HPV miệng ở bệnh nhân nhiễm HIV

Greenspan D, Canchola AJ, MacPhail LA, et al.: Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001, 357:1411–1412. King MD, Reznik DA, O’Daniels CM, et al.: Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002, 34:641–648. Leigh J: Oral warts rise dramatically with use of new agents in HIV. HIV Clin 2000, 12:7. Howley P: Papillomavirinae: the viruses and their replication. In Fields Virology. Edited by Fields BK, Knipe DM, Howley PM. Philadelphia: Lippincott-Raven; 1996:2045–2076. Shah K: Papillomaviruses. In Fields Virology. Edited by Fields BK, Knipe DM, Howley PM. Philadelphia: Lippincott-Raven; 1996:2077–2109. D’souza G, Kreimer AR, Viscidi R, et al.: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944–1956. Hansson BG, Rosenquist K, Antonsson A, et al.: Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005, 125:1337–1344. Herrero R, Castellsague X, Pawlita M, et al.: Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003, 95:1772–1783. Mork J, Lie AK, Glattre E, et al.: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344:1125–1131. Pintos J, Black MJ, Sadeghi N, et al.: Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol 2008, 44:242–250. Ritchie JM, Smith EM, Summersgill KF, et al.: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003, 104:336–344. Schwartz SM, Daling JR, Doody DR, et al.: Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998, 90:1626–1636. Smith EM, Ritchie JM, Summersgill KF, et al.: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004, 108:766–772. Smith EM, Ritchie JM, Pawlita M, et al.: Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer 2006, 120:825–832. Schwartz SM, Daling JR, Shera KA, et al.: Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001, 19:1906–1915. Cannistra SA, Niloff JM: Cancer of the uterine cervix. N Engl J Med 1996, 334:1030–1038. Arany I, Tyring SK: Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum. Int J STD AIDS 1998, 9:268–271. Maiman M: Management of cervical neoplasia in human immunodeficiency virus-infected women. J Natl Cancer Inst Monogr 1998, 43–49. Minkoff H, Feldman J, DeHovitz J, et al.: A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998, 178:982–986. Six C, Heard I, Bergeron C, et al.: Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998, 12:1047–1056. Sun XW, Kuhn L, Ellerbrock TV, et al.: Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997, 337:1343–1349. Maiman M, Fruchter RG, Clark M, et al.: Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1997, 89:76–80. Palefsky J: Biology of HPV in HIV infection. Adv Dent Res 2006, 19:99–105. Ryan DP, Compton CC, Mayer RJ: Carcinoma of the anal canal. N Engl J Med 2000, 342:792–800. Heard I, Schmitz V, Costagliola D, et al.: Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998, 12:1459–1464. Lillo FB, Ferrari D, Veglia F, et al.: Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001, 184:547–551. Lilly EA, Cameron JE, Shetty KV, et al.: Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions. Oral Microbiol Immunol 2005, 20:154–162. Greenspan D, de Villiers EM, Greenspan JS, et al.: Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol 1988, 17:482–488. Itin PH, Lautenschlager S: Viral lesions of the mouth in HIV-infected patients. Dermatology 1997, 194:1–7. Volter C, He Y, Delius H, et al.: Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer 1996, 66:453–456. Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000, 92:1500–1510. Syrijanen S, Puranen M: Human papillomavirus infections in children: the potential role of maternal transmission. Crit Rev Oral Biol Med 2000, 11:259–274. Summersgill KF, Smith EM, Levy BT, et al.: Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:62–69. Coutlee F, Trottier AM, Ghattas G, et al.: Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis 1997, 24:23–31. D’souza G, Fakhry C, Sugar EA, et al.: Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007, 121:143–150. Fakhry C, D’souza G, Sugar E, et al.: Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and-negative women. J Clin Microbiol 2006, 44:4479–4485. Kreimer AR, Alberg AJ, Daniel R, et al.: Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004, 189:686–698. Cameron JE, Mercante D, O’Brien M, et al.: The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis 2005, 32:703–709. Canadas MP, Bosch FX, Junquera ML, et al.: Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol 2004, 42:1330–1332. Marais DJ, Passmore JA, Denny L, et al.: Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa. J Med Virol 2008, 80:953–959. Smith EM, Ritchie JM, Yankowitz J, et al.: HPV prevalence and concordance in the cervix and oral cavity of pregnant women. Infect Dis Obstet Gynecol 2004, 12:45–56. Baccaglini L, Atkinson JC, Patton LL, et al.: Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103(Suppl):S50.e1–S50.e23. Mendenhall WM, Morris CG, Amdur RJ, et al.: Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol 2006, 29:32–39.